Clinical Trials Directory

Trials / Completed

CompletedNCT02684500

Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study

Evaluation of Superior Mesenteric Artery Diameter and Flow in Aneurysmal Subarachnoid Hemorrhage Patients Undergoing Hypertensive Therapy for Cerebral Artery Vasospasm

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to determine if the diameter and flow of the superior mesenteric artery in patients with aneurysmal subarachnoid hemorrhage undergoing hypertensive therapy for cerebral artery vasospasm are effected enough to justify withholding enteral nutrition.

Detailed description

Study measurements of the diameter and Doppler flow velocity of the superior mesenteric artery (SMA) using abdominal ultrasound in order to evaluate the potential additional risk of non-occlusive mesenteric ischemia (NOMI) and non occlusive bowel necrosis (NOBN) in patients undergoing hypertensive therapy for cerebral vasospasm in Aneurysmal Subarachnoid Hemorrhage (aSAH), to justify the withholding of enteral nutrition.

Conditions

Interventions

TypeNameDescription
DEVICEUltrasoundStudy measurements of the diameter and doppler flow velocity of the superior mesenteric artery (SMA) for a aneurysmal subarachnoid hemorrhage using abdominal ultrasound.

Timeline

Start date
2016-04-11
Primary completion
2016-06-30
Completion
2016-06-30
First posted
2016-02-18
Last updated
2020-03-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02684500. Inclusion in this directory is not an endorsement.